Analysts: Allergan Inc (AGN)

AGN on New York Consolidated

212.10USD
25 Nov 2014
Price Change (% chg)

$0.29 (+0.14%)
Prev Close
$211.81
Open
$211.75
Day's High
$213.30
Day's Low
$211.29
Volume
3,484,722
Avg. Vol
2,861,548
52-wk High
$214.20
52-wk Low
$94.98

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.83 December 25 Nov 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 11 9 9
(2) OUTPERFORM 5 7 7 6
(3) HOLD 8 3 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.05 1.62 1.75 1.74

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 16 1,904.64 1,944.27 1,874.70 1,730.84
Quarter Ending Mar-15 5 1,817.18 1,856.30 1,747.00 --
Year Ending Dec-14 19 7,207.88 7,261.97 7,063.60 6,738.82
Year Ending Dec-15 19 7,922.73 8,029.00 7,681.20 7,065.75
Earnings (per share)
Quarter Ending Dec-14 21 1.83 1.93 1.76 1.46
Quarter Ending Mar-15 8 1.82 1.93 1.69 --
Year Ending Dec-14 22 6.30 6.40 6.28 5.42
Year Ending Dec-15 23 8.59 8.85 8.20 5.84
LT Growth Rate (%) 5 21.16 28.78 18.00 12.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 1,783.88 1,817.10 33.22 1.86
Quarter Ending Jun-14 1,772.17 1,854.50 82.33 4.65
Quarter Ending Mar-14 1,603.60 1,646.10 42.50 2.65
Quarter Ending Dec-13 1,646.85 1,684.40 37.55 2.28
Quarter Ending Sep-13 1,529.18 1,558.70 29.52 1.93
Earnings (per share)
Quarter Ending Sep-14 1.68 1.78 0.10 6.23
Quarter Ending Jun-14 1.44 1.51 0.07 4.92
Quarter Ending Mar-14 1.13 1.18 0.05 4.60
Quarter Ending Dec-13 1.34 1.35 0.01 0.87
Quarter Ending Sep-13 1.21 1.23 0.02 2.03

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 1,904.64 1,905.80 1,867.09 1,849.52 1,730.84
Quarter Ending Mar-15 1,817.18 1,817.18 1,786.57 1,801.64 --
Year Ending Dec-14 7,207.88 7,213.52 7,152.27 7,081.96 6,738.82
Year Ending Dec-15 7,922.73 7,927.44 7,851.77 7,757.35 7,065.75
Earnings (per share)
Quarter Ending Dec-14 1.83 1.83 1.75 1.65 1.46
Quarter Ending Mar-15 1.82 1.82 1.80 1.76 --
Year Ending Dec-14 6.30 6.30 6.12 5.80 5.42
Year Ending Dec-15 8.59 8.58 8.43 8.23 5.84

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 12 2
Quarter Ending Mar-15 0 0 2 0
Year Ending Dec-14 0 1 13 3
Year Ending Dec-15 0 2 11 5
Earnings
Quarter Ending Dec-14 0 0 12 1
Quarter Ending Mar-15 0 0 3 1
Year Ending Dec-14 0 0 16 0
Year Ending Dec-15 1 0 15 2

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks